Skip to main content
Journal cover image

Candesartan benefits and safety observed regardless of age. Insights from the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM) program.

Publication ,  Conference
Cohen-Solal, A; Swedberg, K; Mc Murray, J; Pfeffer, M; Olofsson, B; Michelson, E; Yusuf, S; Granger, C
Published in: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
2007

Duke Scholars

Published In

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

ISSN

0735-1097

Publication Date

2007

Volume

49

Issue

9

Start / End Page

55A / 55A

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Cohen-Solal, A., Swedberg, K., Mc Murray, J., Pfeffer, M., Olofsson, B., Michelson, E., … Granger, C. (2007). Candesartan benefits and safety observed regardless of age. Insights from the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM) program. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (Vol. 49, pp. 55A-55A).
Cohen-Solal, Alain, Karl Swedberg, John Mc Murray, Marc Pfeffer, Bertil Olofsson, Eric Michelson, Salim Yusuf, and Christopher Granger. “Candesartan benefits and safety observed regardless of age. Insights from the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM) program.” In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 49:55A-55A, 2007.
Cohen-Solal A, Swedberg K, Mc Murray J, Pfeffer M, Olofsson B, Michelson E, et al. Candesartan benefits and safety observed regardless of age. Insights from the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM) program. In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2007. p. 55A-55A.
Cohen-Solal A, Swedberg K, Mc Murray J, Pfeffer M, Olofsson B, Michelson E, Yusuf S, Granger C. Candesartan benefits and safety observed regardless of age. Insights from the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM) program. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2007. p. 55A-55A.
Journal cover image

Published In

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

ISSN

0735-1097

Publication Date

2007

Volume

49

Issue

9

Start / End Page

55A / 55A

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1102 Cardiorespiratory Medicine and Haematology